The EU on Friday backtracked on a threat to restrict exports of COVID-19 vaccines to Northern Ireland in its growing row with the UK, as the WHO warned against “vaccine nationalism.”
Outbreaks are raging around the globe with COVID-19 deaths nearing 2.2 million, and while wealthy countries fight over limited vaccine supplies, there are fears the less privileged will not get access for a long time.
British-Swedish firm AstraZeneca has said it can only deliver a fraction of its vaccine doses promised to the EU and the UK because of production problems, but both sides are demanding that their pledges are met.
The EU threatened to restrict vaccine exports to Northern Ireland by overriding part of the Brexit deal with the UK that allowed the free flow of goods over the Irish border, but backed down after British Prime Minister Boris Johnson voiced “grave concerns.”
The European Commission would “ensure that the Ireland/Northern Ireland Protocol is unaffected,” the EU commissioner said in a statement late on Friday.
That came after the EU released a redacted version of its contract with AstraZeneca, while announcing a mechanism that could allow it to deny the export of vaccines made on European soil.
The AstraZeneca vaccine on Friday became the third to receive EU approval after Pfizer/BioNTech and Moderna, but it came under the shadow of the bitter diplomatic row.
“I expect the company [AstraZeneca] to deliver the 400 million doses as agreed,” European Commission President Ursula von der Leyen wrote on Twitter as she announced the authorization.
The supply issue is a huge blow to Europe’s already stumbling vaccine rollout.
The EU-UK tussle has highlighted the impact of shortages on ambitious mass vaccination programs, even on wealthy nations, and fears are growing that the developed world is hogging doses, leaving poorer nations behind.
WHO Director-General Tedros Adhanom Ghebreyesus on Friday warned against “vaccine nationalism,” saying there was a “real danger that the very tools that could help to end the pandemic — vaccines — may exacerbate” global inequality.
Parts of Africa and Asia have only just started securing and rolling out vaccinations.
The global scramble for shots comes as more troubling data emerged on new variants of the coronavirus, which is known to have infected more than 101 million people worldwide.
Variants first detected in the UK, Brazil and South Africa are believed to be more contagious.
Scientists are concerned that the South African variant might elude some vaccines, a potential stumbling block in the global effort to defeat COVID-19 through mass inoculation.
New data on Thursday and Friday showed that average effectiveness of 89 and 66 percent for shots from Novavax and Johnson & Johnson respectively.
However, while Novavax’s jab was highly effective against the British variant, both were less effective against the South African strain.
Pfizer and Moderna have said their vaccines are effective against the variants.
An uncrewed Chinese spacecraft has acquired imagery data covering all of Mars, including visuals of its south pole, after circling the planet more than 1,300 times since early last year, state media reported yesterday. The Tianwen-1 successfully reached the Red Planet in February last year on the country’s inaugural mission there. A robotic rover has since been deployed on the surface as an orbiter surveyed the planet from space. Among the images taken from space were China’s first photographs of the Martian south pole, where almost all of the planet’s water resources are locked. In 2018, an orbiting probe operated by the European
QUARANTINE SHORTENED: A new protocol detailing risk levels and local policy responses would be ‘more scientific and accurate,’ a health agency spokesman said China’s revised COVID-19 guidelines, which cut a quarantine requirement in half for inbound travelers, also create a standardized policy for mass testing and lockdowns when cases of the disease flare, showing that the country still has a zero-tolerance approach to the virus. Chinese President Xi Jinping (習近平) solidified the position during a trip to Wuhan, where the pathogen first emerged in 2019, saying that China is capable of achieving a “final victory” over the virus. The “zero COVID-19” policy is the most effective and economic approach for the country, Xi said during the trip on Tuesday, Xinhua news agency reported. The first
A flight test of a hypersonic missile system in Hawaii on Wednesday ended in failure due to a problem that occurred after ignition, the US Department of Defense said, delivering a fresh blow to a program that has experienced stumbles. It did not provide details of what took place in the test, but said in an e-mailed statement that “the department remains confident that it is on track to field offensive and defensive hypersonic capabilities on target dates beginning in the early 2020s.” “An anomaly occurred following ignition of the test asset,” Pentagon spokesman US Navy Lieutenant Commander Tim Gorman said in
China is racing to quash a new COVID-19 flareup that risks spilling over into one of its most economically significant regions, raising the specter of disruptions that could roil global supply chains for solar panels, medicines and semiconductors. Infections have surged in Si County in the eastern province of Anhui, with officials reporting 287 cases for Sunday and nearly 1,000 since late last week. Authorities locked down Si and a neighboring county late last week to try and stop the virus from spreading to Jiangsu Province, the second-biggest contributor to China’s economic output and a globally important manufacturing hub for the